ZA943690B - Imidazole 5-position substituted angiotensin II antagonists - Google Patents

Imidazole 5-position substituted angiotensin II antagonists

Info

Publication number
ZA943690B
ZA943690B ZA943690A ZA943690A ZA943690B ZA 943690 B ZA943690 B ZA 943690B ZA 943690 A ZA943690 A ZA 943690A ZA 943690 A ZA943690 A ZA 943690A ZA 943690 B ZA943690 B ZA 943690B
Authority
ZA
South Africa
Prior art keywords
antagonists
imidazole
position substituted
angiotensin
substituted angiotensin
Prior art date
Application number
ZA943690A
Other languages
English (en)
Inventor
John Jonas Vytautas Duncia
Carol Lee Ensinger
Richard Eric Olson
Mimi Lifen Quan
Joseph Basil Santella Iii
Mary Katherine Vanatten
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA943690B publication Critical patent/ZA943690B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA943690A 1993-06-10 1994-05-26 Imidazole 5-position substituted angiotensin II antagonists ZA943690B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/072,977 US5395844A (en) 1993-06-10 1993-06-10 Imidazole 5-position substituted angiotensin II antagonists

Publications (1)

Publication Number Publication Date
ZA943690B true ZA943690B (en) 1995-11-27

Family

ID=22110952

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943690A ZA943690B (en) 1993-06-10 1994-05-26 Imidazole 5-position substituted angiotensin II antagonists

Country Status (10)

Country Link
US (2) US5395844A (ja)
EP (1) EP0711162A4 (ja)
JP (1) JPH08511774A (ja)
AU (1) AU7201694A (ja)
CA (1) CA2164583A1 (ja)
HR (1) HRP940346A2 (ja)
IL (1) IL109782A0 (ja)
TW (1) TW269683B (ja)
WO (1) WO1994028896A1 (ja)
ZA (1) ZA943690B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034114A (en) * 1990-12-14 2000-03-07 Smithkline Beecham Plc Medicament
US5187271A (en) * 1991-02-28 1993-02-16 G. D. Searle & Co. N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
US6008368A (en) * 1993-04-28 1999-12-28 G. D. Searle & Co. Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists
TW300219B (ja) * 1991-09-14 1997-03-11 Hoechst Ag
FR2716882B1 (fr) * 1994-03-04 1996-04-05 Roussel Uclaf Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
DE4432860A1 (de) * 1994-09-15 1996-03-21 Merck Patent Gmbh Imidazopyridine
SK18097A3 (en) * 1996-02-28 1997-10-08 American Cyanamid Co Substituted omega £phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl| £alkyl, alkenyl or alkinyl|amino carboxamides, sulfonamides and phosphonyl amides, pharmaceutical preparation containing them, process for producing them and their use
IT1295405B1 (it) 1997-09-30 1999-05-12 Merck Sharp & Dohme Italia S P Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
US7063709B2 (en) * 2002-06-11 2006-06-20 Boston Scientific Scimed, Inc. Ligating band dispenser with transverse ridge profile
ES2425567T3 (es) 2004-12-24 2013-10-16 Spinifex Pharmaceuticals Pty Ltd Método de tratamiento o profilaxis
MX2007012635A (es) 2005-04-12 2008-01-11 Vicore Pharma Ab Nuevos agonistas de angiotensina ii triciclica.
US8080571B2 (en) 2005-04-12 2011-12-20 Vicore Pharma Ab Tricyclic angiotensin II agonists
IN2014DN02217A (ja) 2005-04-12 2015-07-10 Vicore Pharma Ab
US20130131007A1 (en) 2005-09-07 2013-05-23 Bebaas, Inc. Vitamin b12 compositions
CN102885818B (zh) 2006-03-20 2016-05-04 诺华股份有限公司 治疗或预防炎性痛的方法
GB0720444D0 (en) * 2007-10-18 2007-11-28 Glaxo Group Ltd Novel compounds
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
US7989484B2 (en) * 2008-04-29 2011-08-02 Theravance, Inc. Dual-acting antihypertensive agents
WO2010039977A2 (en) 2008-10-01 2010-04-08 Amira Pharmaceuticals, Inc. Heteroaryl antagonists of prostaglandin d2 receptors
EP2755966B1 (en) 2011-09-13 2017-03-15 Brookhaven Science Associates LLC Bimetallic catalysts for co2 hydrogenation and h2 generation from formic acid and/or salts thereof
EP2967049B1 (en) * 2013-03-15 2020-09-02 University Of Southern California Methods, compounds, and compositions for the treatment of angiotensin-related diseases
US9816740B1 (en) * 2016-06-09 2017-11-14 Mainstream Engineering Corporation HVAC/R system refrigerant and oil conditioning, composition, and method for removing acid and moisture therewith
JP2020142989A (ja) * 2017-06-21 2020-09-10 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 イミダゾール誘導体及びそれを含有する医薬
GB2605148A (en) * 2021-03-23 2022-09-28 Vicore Pharma Ab New compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5128125A (en) * 1988-02-16 1992-07-07 Barnes Arthur C Method for preparing finely divided nylon-4 complex with iodine and antiseptic preparation made therefrom
IL98319A (en) * 1990-07-05 1997-04-15 Roussel Uclaf Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
CA2058198A1 (en) * 1991-01-04 1992-07-05 Adalbert Wagner Azole derivatives, process for their preparation, and their use
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
US5218125A (en) * 1992-04-23 1993-06-08 Merck & Co., Inc. Antihypertensive compound and method of use thereas
US5217882A (en) * 1992-05-18 1993-06-08 Merck & Co., Inc. Microbial transformation process for producing antihypertensive N2 -glucuronide products

Also Published As

Publication number Publication date
US5395844A (en) 1995-03-07
CA2164583A1 (en) 1994-12-22
EP0711162A4 (en) 1996-09-04
US5545651A (en) 1996-08-13
IL109782A0 (en) 1994-08-26
EP0711162A1 (en) 1996-05-15
WO1994028896A1 (en) 1994-12-22
HRP940346A2 (en) 1996-12-31
JPH08511774A (ja) 1996-12-10
TW269683B (ja) 1996-02-01
AU7201694A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
ZA943690B (en) Imidazole 5-position substituted angiotensin II antagonists
IL105877A0 (en) Angiotensin ii antagonists
AU8374491A (en) Angiotensin II receptor antagonists
AU3122793A (en) Substituted heterocycles as angiotensin ii antagonists
EP0409332A3 (en) Substituted triazoles as angiotensin ii antagonists
EP0412594A3 (en) Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin ii antagonists
IL125282A0 (en) Novel substituted imidazole compounds
ZA985764B (en) Novel substituted imidazole compounds
ZA912656B (en) Substituted benzimidazoles having angiotensin 11 receptor antagonisn
EP0515546A4 (en) Triazole angiotensin ii antagonists incorporating a substituted benzyl element
EP0574787A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
ZA985763B (en) Novel substituted imidazole compounds
AU3276293A (en) Angiotensin II receptor antagonists
GB9317760D0 (en) Angiotensin ii antagonist
HU9601176D0 (en) Adhesion-receptor antagonists
GB9317758D0 (en) Angiotensin ii antagonist
HRP970155A2 (en) Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists
EP0515548A4 (en) Imidazole angiotensin ii antagonists incorporating a substituted benzyl element
IL110239A0 (en) Azacyclic - heterocyclic compounds as angiotensin II receptor antagonists
EP0591891A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
EP0546449A3 (en) Benzofuranderivatives as angiotensin ii antagonists
IL108843A0 (en) Benzylimidazopyridine derivative as angiotensin II receptor antagonist
AU5376194A (en) Heterocyclic compounds as angiotensin ii antagonists
AU4348593A (en) Chromanderivatives as angiotensin ii antagonists
GB9320941D0 (en) Substituted hexaydrobenzopyran derivatives as angiotensin 11 antagonists